Combining glomerular basement membrane and tubular basement membrane assessment improves the prediction of diabetic end-stage renal disease. 2021

Lijun Zhao, and Junlin Zhang, and Song Lei, and Honghong Ren, and Yutong Zou, and Lin Bai, and Rui Zhang, and Huan Xu, and Lin Li, and Yuancheng Zhao, and Mark E Cooper, and Nanwei Tong, and Jie Zhang, and Fang Liu
Division of Nephrology, West China Hospital of Sichuan University, Chengdu, China.

BACKGROUND To address the prognostic value of combining tubular basement membrane (TBM) and glomerular basement membrane (GBM) thickness in diabetic nephropathy (DN). METHODS This retrospective study enrolled 110 patients with type 2 diabetes and biopsy-proven DN from 2011 to 2018. The pathological findings were confirmed according to the Renal Pathology Society classifications. GBM and TBM thicknesses were determined using the Haas' direct measurement/arithmetic mean method and orthogonal intercept method, respectively. Cox proportional hazard models were used to investigate the hazard ratios (HRs) for the influence of combined GBM and TBM thickness for predicting end-stage renal disease (ESRD). RESULTS Patients were assigned to three groups according to the median GBM and TBM thickness: GBMlo TBMlo (GBM < 681 nm and TBM < 1200 nm), GBMhi TBMlo /GBMlo TBMhi (GBM ≥ 681 nm and TBM < 1200 nm, or GBM < 681 nm and TBM ≥ 1200 nm), and GBMhi TBMhi (GBM ≥ 681 nm and TBM ≥ 1200 nm). The GBMhi TBMlo /GBMlo TBMhi and GBMhi TBMhi groups displayed poorer renal function, a more severe glomerular classification and interstitial inflammation, and poorer renal survival rates than the GBMlo TBMlo group The GBMhi TBMlo /GBMlo TBMhi and GBMhi TBMhi groups had adjusted HRs of 1.49 (95% confidence interval [CI], 1.21-9.75) and 3.07 (95% CI, 2.87-12.78), respectively, compared with the GBMlo TBMlo group. CONCLUSIONS TBM thickness enhanced GBM thickness for renal prognosis in patients with type 2 diabetes.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007684 Kidney Tubules Long convoluted tubules in the nephrons. They collect filtrate from blood passing through the KIDNEY GLOMERULUS and process this filtrate into URINE. Each renal tubule consists of a BOWMAN CAPSULE; PROXIMAL KIDNEY TUBULE; LOOP OF HENLE; DISTAL KIDNEY TUBULE; and KIDNEY COLLECTING DUCT leading to the central cavity of the kidney (KIDNEY PELVIS) that connects to the URETER. Kidney Tubule,Tubule, Kidney,Tubules, Kidney
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Lijun Zhao, and Junlin Zhang, and Song Lei, and Honghong Ren, and Yutong Zou, and Lin Bai, and Rui Zhang, and Huan Xu, and Lin Li, and Yuancheng Zhao, and Mark E Cooper, and Nanwei Tong, and Jie Zhang, and Fang Liu
March 2013, Kidney international,
Lijun Zhao, and Junlin Zhang, and Song Lei, and Honghong Ren, and Yutong Zou, and Lin Bai, and Rui Zhang, and Huan Xu, and Lin Li, and Yuancheng Zhao, and Mark E Cooper, and Nanwei Tong, and Jie Zhang, and Fang Liu
January 2019, Clinical nephrology. Case studies,
Lijun Zhao, and Junlin Zhang, and Song Lei, and Honghong Ren, and Yutong Zou, and Lin Bai, and Rui Zhang, and Huan Xu, and Lin Li, and Yuancheng Zhao, and Mark E Cooper, and Nanwei Tong, and Jie Zhang, and Fang Liu
June 2010, Nihon rinsho. Japanese journal of clinical medicine,
Lijun Zhao, and Junlin Zhang, and Song Lei, and Honghong Ren, and Yutong Zou, and Lin Bai, and Rui Zhang, and Huan Xu, and Lin Li, and Yuancheng Zhao, and Mark E Cooper, and Nanwei Tong, and Jie Zhang, and Fang Liu
January 2023, Nephron,
Lijun Zhao, and Junlin Zhang, and Song Lei, and Honghong Ren, and Yutong Zou, and Lin Bai, and Rui Zhang, and Huan Xu, and Lin Li, and Yuancheng Zhao, and Mark E Cooper, and Nanwei Tong, and Jie Zhang, and Fang Liu
August 1990, Lancet (London, England),
Lijun Zhao, and Junlin Zhang, and Song Lei, and Honghong Ren, and Yutong Zou, and Lin Bai, and Rui Zhang, and Huan Xu, and Lin Li, and Yuancheng Zhao, and Mark E Cooper, and Nanwei Tong, and Jie Zhang, and Fang Liu
February 1977, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
Lijun Zhao, and Junlin Zhang, and Song Lei, and Honghong Ren, and Yutong Zou, and Lin Bai, and Rui Zhang, and Huan Xu, and Lin Li, and Yuancheng Zhao, and Mark E Cooper, and Nanwei Tong, and Jie Zhang, and Fang Liu
October 1976, Biochemical and biophysical research communications,
Lijun Zhao, and Junlin Zhang, and Song Lei, and Honghong Ren, and Yutong Zou, and Lin Bai, and Rui Zhang, and Huan Xu, and Lin Li, and Yuancheng Zhao, and Mark E Cooper, and Nanwei Tong, and Jie Zhang, and Fang Liu
October 2012, Translational research : the journal of laboratory and clinical medicine,
Lijun Zhao, and Junlin Zhang, and Song Lei, and Honghong Ren, and Yutong Zou, and Lin Bai, and Rui Zhang, and Huan Xu, and Lin Li, and Yuancheng Zhao, and Mark E Cooper, and Nanwei Tong, and Jie Zhang, and Fang Liu
April 1990, The New England journal of medicine,
Lijun Zhao, and Junlin Zhang, and Song Lei, and Honghong Ren, and Yutong Zou, and Lin Bai, and Rui Zhang, and Huan Xu, and Lin Li, and Yuancheng Zhao, and Mark E Cooper, and Nanwei Tong, and Jie Zhang, and Fang Liu
December 1975, Diabete & metabolisme,
Copied contents to your clipboard!